Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine versus risperidone for ADHD in preschool children
IRCT20260123068641N1Phase 4Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in attention deficit hyperactivity disorder (ADHD) comparing Risperidone with Quetiapine (2 arms). Primary endpoints: Change in ADHD symptom severity and Change in overall child functioning. Started Mar 2026; status: completed.
02
Drugs
quetiapinerisperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20260123068641N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260123068641N1.